Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL (Diatrizoate Meglumine and Diatrizoate Sodium SOLUTION) 660 mg/mL

Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL is a radiopaque contrast agent used for diagnostic imaging procedures. This solution aids in enhancing visibility during X-rays and other imaging techniques.

Strength

660 mg/mL

Pack Size

24 BOTTLE in 1 BOX (31722-019-31) / 30 mL in 1 BOTTLE (31722-019-30)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL is primarily used as a contrast medium to improve the visibility of internal structures during radiographic imaging. It is commonly administered orally or rectally to facilitate the examination of the gastrointestinal tract. This solution helps in identifying abnormalities and providing clear images for diagnostic purposes.

Side Effects

Common effects of Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL may include a temporary sensation of warmth or flushing. Some individuals might experience mild nausea or a metallic taste in the mouth. These effects are generally short-lived and subside quickly.

Precautions & Warnings

Handle Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL with care, ensuring it is stored at the recommended temperature. Always follow the instructions provided by healthcare professionals for safe administration. Avoid contact with eyes and skin, and wash hands thoroughly after handling.

Avoid Interactions

Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL may interact with certain medications, including other contrast agents and some types of diuretics. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol consumption should be avoided before and after administration.

Frequently Asked Questions

Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL is used as a contrast agent to enhance visibility during radiographic imaging of the gastrointestinal tract.

This solution is typically administered orally or rectally, depending on the specific diagnostic procedure.

Common effects may include a temporary sensation of warmth, flushing, mild nausea, or a metallic taste in the mouth.

Yes, it should be handled with care, stored properly, and administered under the guidance of healthcare professionals.

Yes, it may interact with other contrast agents and some types of diuretics, so it's important to inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.